GSK signs £64m autoimmune antibody deal
January 7, 2011Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases
GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …
Sanofi workers strike in France
January 7, 2011Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions
Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
Clare Panter joins Woolley Pau PR
January 7, 2011Medical Communications Clare Panter, Woolley Pau, appointment, medical communications
Clare Panter has joined Woolley Pau’s PR arm as a PR account executive. She is a keen writer and recently …
Study highlights Avastin heart failure risk
January 6, 2011Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer
A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …
Biogen Idec appoints new head of R&D
January 6, 2011Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing
Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …
Janssen’s Invega wins schizoaffective approval in Europe
January 6, 2011Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia
Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …
Leukaemia drug fast-tracked by NICE
January 6, 2011Sales and Marketing Bendamustine, Levact, NICE, Napp, chronic lymphocytic leukaemia, leukaemia
A treatment for patients with the most common form of leukaemia has been fast tracked by NICE because of strong …
Bayer submits new Xarelto indications for European approval
January 6, 2011Sales and Marketing Bayer, DVT, Xarelto, atrial fibrillation, deep vein thrombosis, pulmonary embolism, rivaroxaban, stroke prevention
Bayer is seeking European regulatory approval for a batch of new indications for its oral anticoagulant Xarelto. The company is …
GSK hits back at 60 Minutes whistleblower interview
January 6, 2011Manufacturing and Production 60 Minutes, Avandamet, Bactroban, Cheryl Eckard, GSK, GlaxoSmithKline, Kytril, Paxil, manufacturing compliance
GlaxoSmithKline has responded to an edition of US current affairs show 60 Minutes centring on manufacturing problems at its now-closed …
BMS appoints Dr Veronique Walsh
January 5, 2011Sales and Marketing BMS, Bristol-Myers Squibb, Dr Véronique Walsh, appointment, sales and marketing
Bristol-Myers Squibb UK has appointed Dr Véronique Walsh as business unit director, neuroscience and immunoscience . She joins the company …
Merck KGaA opens outsourcing centre in India
January 5, 2011Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing
Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …
Contract research news in brief
January 5, 2011Research and Development Accel Synthesis, Almac, Bioanalytical Systems, Caliper Life Sciences, Cambridge Research & Instrumentation, Critical Path Services, Pharmasset, ReSearch Pharmaceutical Services, ResourcingPoint, Warburg Pincus
Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …
Flu ad campaign dusted off as cases rise
January 5, 2011Medical Communications NHS, UK, disease awareness, flu, influenza
The Department of Health this week relaunched its advertising campaign to remind people of the importance of good hand and …
NHS faces its toughest ever year
January 5, 2011BMA, NHS, NHS Confederation, NHS White Paper, NHS reforms, clinical commissioning
Doctors leaders and healthcare managers have used their New Year messages to warn of hard times in 2011 for the …
EDC is Now – The Changing
January 5, 2011Research and Development
Clinical research is rapidly moving toward the electronic environment as more han half of all studies are conducted utilizing EDC, …
Pfizer pays $63m for generics portfolio
January 5, 2011Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables
Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …
GSK’s Dr Anne Phillips moves to Novo Nordisk
January 4, 2011Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing
Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Digital Pharma: First big pharma Android apps launched
January 4, 2011Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone
Big pharma’s smartphone marketing is starting to look beyond Apple’s attention-grabbing iPhone as companies produce the first apps for its …
NICE’s public health role reduced
January 4, 2011NHS, NHS reforms, NICE, public health, quality standards
NICE’s public health remit has been slimmed down as part of the government’s reforms with the removal of six areas …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
